Acute lung injury (ALI) and its more severe form, acute respiratory distress syndrome
(ARDS) as common life-threatening lung diseases with high mortality rates are mostly …

Introduction: Mesenchymal stromal (stem) cell (MSC) therapies are emerging as a promising
therapeutic intervention in patients with Acute Respiratory Distress Syndrome (ARDS) and …

Abstract During the 2020 Spring Festival in China, the outbreak of a novel coronavirus,
named COVID‐19 by WHO, brought on a worldwide panic. According to the clinical data of …

Background Macrophage polarization and reprogramming in the lung play a critical role in
the initiation, development and progression of acute lung injury (ALI). Regulating the …

Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a common life‐
threatening syndrome with no effective pharmacotherapy. Sepsis‐related ARDS is the main …

Abstract Background Mesenchymal stromal cells (MSCs) may be of benefit in acute
respiratory distress syndrome (ARDS) due to immunomodulatory, reparative, and …

As aerobic organisms, we are continuously and throughout our lifetime subjected to an
oxidizing atmosphere and, most often, to environmental threats. The lung is the internal …

Acute respiratory distress syndrome (ARDS) can be induced by multiple clinical factors,
including sepsis, acute pancreatitis, trauma, intestinal ischemia/reperfusion and burns …

Recent advances in mRNA technology and its delivery have enabled mRNA-based
therapeutics to enter a new era in medicine. The rapid, potent, and transient nature of mRNA …

There is an urgent need for new antimicrobial strategies for treating complex infections and
emerging pathogens. Human mesenchymal stromal cells (MSCs) are adult multipotent cells …